First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
09 12 2021
Historique:
pubmed: 30 11 2021
medline: 22 1 2022
entrez: 29 11 2021
Statut: ppublish

Résumé

MINA53 is a JmjC domain 2-oxoglutarate-dependent oxygenase that catalyzes ribosomal hydroxylation and is a target of the oncogenic transcription factor

Identifiants

pubmed: 34843649
doi: 10.1021/acs.jmedchem.1c00605
pmc: PMC8667043
doi:

Substances chimiques

Enzyme Inhibitors 0
Nuclear Proteins 0
Dioxygenases EC 1.13.11.-
Histone Demethylases EC 1.14.11.-
RIOX2 protein, human EC 1.14.11.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17031-17050

Subventions

Organisme : Cancer Research UK
ID : C8717/A18245
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 106244/Z/14/Z
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A23900
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N021053/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L009846/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C33483/A25674
Pays : United Kingdom

Références

Cell Death Dis. 2018 Oct 17;9(11):1062
pubmed: 30333481
Cell Rep. 2016 Mar 22;14(11):2745-60
pubmed: 26972000
Oncogene. 2017 Jan 19;36(3):387-396
pubmed: 27292258
J Med Chem. 2005 Jan 13;48(1):200-12
pubmed: 15634014
Chem Soc Rev. 2011 Aug;40(8):4364-97
pubmed: 21390379
Nat Chem Biol. 2016 Jul;12(7):531-8
pubmed: 27214401
Mol Cell Proteomics. 2009 Mar;8(3):535-46
pubmed: 18936059
Oncotarget. 2016 Mar 8;7(10):11332-48
pubmed: 26870991
Sci Rep. 2016 Nov 11;6:36305
pubmed: 27833099
Cancers (Basel). 2020 May 02;12(5):
pubmed: 32370161
Mol Cell. 2014 Feb 20;53(4):645-54
pubmed: 24486019
Eur J Cell Biol. 2005 Mar;84(2-3):279-94
pubmed: 15819408
Chem Sci. 2013 Aug 1;4(8):3110-3117
pubmed: 26682036
FASEB J. 2015 Jun;29(6):2555-65
pubmed: 25746793
Nat Chem Biol. 2016 Jul;12(7):539-45
pubmed: 27214403
Am J Pathol. 2004 Jan;164(1):205-16
pubmed: 14695334
Ann Surg Oncol. 2017 Mar;24(3):841-849
pubmed: 27473587
Cell Mol Life Sci. 2018 Nov;75(22):4093-4105
pubmed: 30151692
J Appl Crystallogr. 2015 Apr 25;48(Pt 3):927-932
pubmed: 26089766
Anal Biochem. 2010 Sep 1;404(1):86-93
pubmed: 20435012
J Chem Inf Model. 2009 Jan;49(1):84-96
pubmed: 19125657
J Biol Chem. 2002 Sep 20;277(38):35450-9
pubmed: 12091391
Genes Cancer. 2017 Jul;8(7-8):650-658
pubmed: 28966726
Mol Cancer Ther. 2007 Feb;6(2):542-51
pubmed: 17308053
J Am Chem Soc. 2005 Jun 1;127(21):7680-1
pubmed: 15913349
Hematol Oncol. 2019 Oct;37(4):513-515
pubmed: 30991463
FEBS J. 2011 Apr;278(7):1086-97
pubmed: 21251231
J Biol Chem. 2016 Sep 23;291(39):20661-73
pubmed: 27502280
J Phys Chem B. 2018 Aug 30;122(34):8113-8121
pubmed: 30084252
Nature. 2012 Aug 16;488(7411):404-8
pubmed: 22842901
J Biomol Screen. 2012 Jan;17(1):39-48
pubmed: 21859681
Semin Cancer Biol. 2019 Aug;57:27-35
pubmed: 31276784
Medchemcomm. 2014 Dec 1;5(12):1879-1886
pubmed: 26682034
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Nat Chem Biol. 2018 Jul;14(7):688-695
pubmed: 29915238
Nat Chem Biol. 2012 Dec;8(12):960-962
pubmed: 23103944
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):406-418
pubmed: 31034925
Cell Cycle. 2009 Jul 1;8(13):2101-9
pubmed: 19502796
Nature. 2013 Apr 25;496(7446):461-8
pubmed: 23467089
J Biol Chem. 2002 Jul 19;277(29):26351-5
pubmed: 12042299
Methods Mol Biol. 2014;1091:73-94
pubmed: 24203325
Chem Sci. 2017 Nov 1;8(11):7651-7668
pubmed: 29435217
Cell Struct Funct. 2013;38(2):155-67
pubmed: 23748603
Nature. 2014 Jun 19;510(7505):422-426
pubmed: 24814345
Acta Crystallogr D Biol Crystallogr. 2015 Sep;71(Pt 9):1955-64
pubmed: 26327385
J Med Chem. 2012 Jul 26;55(14):6639-43
pubmed: 22724510
Future Med Chem. 2018 May 1;10(9):1067-1091
pubmed: 29676588
EMBO J. 2010 Jan 6;29(1):68-79
pubmed: 19927124
J Struct Biol. 2010 Oct;172(1):3-13
pubmed: 20541610
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1260-73
pubmed: 23793152
Nat Commun. 2016 Aug 26;7:12673
pubmed: 27561929

Auteurs

Radosław P Nowak (RP)

Botnar Research Centre, Nuffield Orthopaedic Centre, University of Oxford, Headington OX3 7LD, U.K.

Anthony Tumber (A)

Botnar Research Centre, Nuffield Orthopaedic Centre, University of Oxford, Headington OX3 7LD, U.K.
Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, 12, Mansfield Road, University of Oxford, Oxford OX1 3TA, U.K.

Eline Hendrix (E)

Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.

Mohammad Salik Zeya Ansari (MSZ)

Institute of Molecular Biology and Pathology (IMBP), National Research Council (CNR) c/o Department of Biology and Biotechnology "Charles Darwin" Sapienza University of Rome, Via degli Apuli 4, Rome 00185, Italy.

Manuela Sabatino (M)

Rome Center for Molecular Design, Department of Chemistry and Technology of Drugs, ″Sapienza″ University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Lorenzo Antonini (L)

Rome Center for Molecular Design, Department of Chemistry and Technology of Drugs, ″Sapienza″ University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Regina Andrijes (R)

Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.

Eidarus Salah (E)

Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, 12, Mansfield Road, University of Oxford, Oxford OX1 3TA, U.K.

Nicola Mautone (N)

Department of Chemistry and Technology of Drugs, ″Sapienza″ University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Francesca Romana Pellegrini (FR)

Institute of Molecular Biology and Pathology (IMBP), National Research Council (CNR) c/o Department of Biology and Biotechnology "Charles Darwin" Sapienza University of Rome, Via degli Apuli 4, Rome 00185, Italy.

Klemensas Simelis (K)

Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, 12, Mansfield Road, University of Oxford, Oxford OX1 3TA, U.K.

Akane Kawamura (A)

Chemistry - School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne NE1 7RU, U.K.

Catrine Johansson (C)

Botnar Research Centre, Nuffield Orthopaedic Centre, University of Oxford, Headington OX3 7LD, U.K.
Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, 12, Mansfield Road, University of Oxford, Oxford OX1 3TA, U.K.

Daniela Passeri (D)

TES Pharma S.r.l. Via P. Togliatti 20, Corciano, Perugia 06073, Italy.

Roberto Pellicciari (R)

TES Pharma S.r.l. Via P. Togliatti 20, Corciano, Perugia 06073, Italy.

Alessia Ciogli (A)

Department of Chemistry and Technology of Drugs, ″Sapienza″ University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Donatella Del Bufalo (D)

Preclinical Models and New Therapeutic Agents Unit, IRCCS-Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome 00144, Italy.

Rino Ragno (R)

Rome Center for Molecular Design, Department of Chemistry and Technology of Drugs, ″Sapienza″ University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Mathew L Coleman (ML)

Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.

Daniela Trisciuoglio (D)

Institute of Molecular Biology and Pathology (IMBP), National Research Council (CNR) c/o Department of Biology and Biotechnology "Charles Darwin" Sapienza University of Rome, Via degli Apuli 4, Rome 00185, Italy.

Antonello Mai (A)

Department of Chemistry and Technology of Drugs, ″Sapienza″ University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Udo Oppermann (U)

Botnar Research Centre, Nuffield Orthopaedic Centre, University of Oxford, Headington OX3 7LD, U.K.

Christopher J Schofield (CJ)

Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, 12, Mansfield Road, University of Oxford, Oxford OX1 3TA, U.K.

Dante Rotili (D)

Department of Chemistry and Technology of Drugs, ″Sapienza″ University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH